drugset / Trial / NCT05363670
Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
RandomizedCrossoverOpen-labelTreatment
Summary
ARS-1 is being developed for patients as a needleless alternative route of epinephrine administration for the management of refractory asthma symptoms.
Timeline
- Start
- 2022-07-28
- Primary completion
- 2024-02-02
- Completion
- 2024-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ARS-1 | Unknown | 1 mg | Intranasal |
| Comparator | ARS-1 | Unknown | 2 mg | Intranasal |
| Comparator | Salbutamol | Unknown | 180 ug | Inhaled |